Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 8 (August)

1. Abnormal anterior cingulum integrity in bipolar disorder determined through diffusion tensor imaging.
   Br J Psychiatry, 193(2): 126-9. [Abstract] [Full-text]
2. Increases in medicare prescription drug plan costs attributable to psychotropic medications.
   Am J Geriatr Psychiatry, 16(8): 674-85. [Abstract] [Full-text]
3. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
   Biol Psychiatry, 64(4): 281-5. [Abstract] [Full-text]
4. The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder.
   Neuroimage, 42(2): 817-26. [Abstract] [Full-text]
5. Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder.
   Psychoneuroendocrinology, 33(7): 1004-12. [Abstract] [Full-text]
6. Identification of loci associated with schizophrenia by genome-wide association and follow-up.
   Nat Genet. [Abstract] [Full-text]
7. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
   Psychol Med, 38(9): 1241-9. [Abstract] [Full-text]
8. Access to medical care among persons with psychotic and major affective disorders.
   Psychiatr Serv, 59(8): 847-52. [Abstract] [Full-text]
9. Comparison of mania patients suitable for treatment trials versus clinical treatment.
   Hum Psychopharmacol, 23(6): 447-54. [Abstract] [Full-text]
10. ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents.
    Child Adolesc Psychiatry Ment Health, 2(1): 15. [Abstract] [Full-text]
11. Molecular mechanisms of stress-induced prefrontal cortical impairment: implications for mental illness.
    Learn Mem, 15(8): 551-64. [Abstract] [Full-text]
12. Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
    Bioorg Med Chem, 16(15): 7516-24. [Abstract] [Full-text]
13. Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice.
    Behav Pharmacol, 19(5): 562-5. [Abstract] [Full-text]
14. Gamma-band auditory steady-state responses are impaired in first episode psychosis.
    Biol Psychiatry, 64(5): 369-75. [Abstract] [Full-text]
15. Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia.
    Biol Psychiatry, 64(5): 419-27. [Abstract] [Full-text]
16. Association of a nonsynonymous variant of DAOA with visuospatial ability in a bipolar family sample.
    Biol Psychiatry, 64(5): 438-42. [Abstract] [Full-text]
17. Neural basis of abnormal response to negative feedback in unmedicated mood disorders.
    Neuroimage, 42(3): 1118-26. [Abstract] [Full-text]
18. Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice.
    Neuropsychopharmacology, 33(10): 2407-15. [Abstract] [Full-text]
19. Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder.
    Acta Psychiatr Scand, 118(2): 106-15. [Abstract] [Full-text]
20. Treating bipolar disorder in patients with renal failure having haemodialysis: two case reports.
    Clin Pract Epidemol Ment Health, 4: 21. [Abstract] [Full-text]
21. Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers?
    Acta Psychiatr Scand, 118(3): 172-87. [Abstract] [Full-text]
22. Temperament and personality dimensions in suicidal and nonsuicidal psychiatric inpatients.
    Psychopathology, 41(5): 313-21. [Abstract] [Full-text]
23. Identifying patterns in treatment response profiles in acute bipolar mania: a cluster analysis approach.
    BMC Psychiatry, 8: 65. [Abstract] [Full-text]
24. Animal models of psychiatric disease.
    Curr Opin Genet Dev. [Abstract] [Full-text]
25. Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
    Ann Pharmacother, 42(9): 1229-38. [Abstract] [Full-text]
26. Bipolar disorder: candidate drug targets.
    Mt Sinai J Med, 75(3): 226-247. [Abstract] [Full-text]
27. Bipolarity in depressive patients without histories of diagnosis of bipolar disorder and the use of the Mood Disorder Questionnaire for detecting bipolarity.
    Compr Psychiatry, 49(5): 469-75. [Abstract] [Full-text]
28. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
    J Psychiatr Res, 42(12): 1037-41. [Abstract] [Full-text]
29. Two structurally distinct inhibitors of glycogen synthase kinase 3 induced centromere positive micronuclei in human lymphoblastoid TK6 cells.
    Mutat Res, 643(1): 29-35. [Abstract] [Full-text]
30. Differential effect of carbamazepine and oxcarbazepine on excitatory synaptic transmission in rat hippocampus.
    Synapse, 62(10): 783-9. [Abstract] [Full-text]
31. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort.
    J Psychiatr Res, 42(12): 982-90. [Abstract] [Full-text]
32. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania.
    Mol Psychiatry, 13(9): 858-72. [Abstract] [Full-text]
33. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder.
    Mol Psychiatry, 13(9): 829, 833-57. [Abstract] [Full-text]
34. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
    Nat Genet. [Abstract] [Full-text]
35. Exchangeable models of complex inherited diseases.
    Genetics, 179(4): 2253-61. [Abstract] [Full-text]
36. Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci, 258(5): 300-4. [Abstract] [Full-text]
37. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Neuroscience, 155(3): 567-72. [Abstract] [Full-text]
38. Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response.
    J Am Acad Child Adolesc Psychiatry, 47(9): 1077-85. [Abstract] [Full-text]
39. Bipolar disorder in late life: clinical characteristics in a sample of older adults admitted for manic episode.
    Clin Pract Epidemol Ment Health, 4: 22. [Abstract] [Full-text]
40. No change to grey and white matter volumes in bipolar I disorder patients.
    Eur Arch Psychiatry Clin Neurosci, 258(6): 345-9. [Abstract] [Full-text]
41. Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci, 258(6): 350-6. [Abstract] [Full-text]
42. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Int Clin Psychopharmacol, 23(5): 254-62. [Abstract] [Full-text]
43. Circadian phenotype in patients with the co-morbid alcohol use and bipolar disorders.
    Alcohol Alcohol, 43(5): 564-8. [Abstract] [Full-text]
44. Illness duration and total brain gray matter in bipolar disorder: evidence for neurodegeneration?
    Eur Neuropsychopharmacol, 18(10): 717-22. [Abstract] [Full-text]
45. CBCL Pediatric Bipolar Disorder Profile and ADHD: Comorbidity and Quantitative Trait Loci Analysis.
    J Am Acad Child Adolesc Psychiatry. [Abstract] [Full-text]
46. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
    Biol Psychiatry, 64(6): 468-75. [Abstract] [Full-text]
47. Clinical epidemiology in patients admitted at Mathari Psychiatric Hospital, Nairobi, Kenya.
    Soc Psychiatry Psychiatr Epidemiol, 43(9): 736-42. [Abstract] [Full-text]
48. Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task.
    Biol Psychiatry, 64(6): 513-20. [Abstract] [Full-text]
49. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.
    Biol Psychiatry, 64(6): 455-60. [Abstract] [Full-text]
50. Lithium-induced suppression of transcription repressor NRSF/REST: effects on the dysfunction of neuronal differentiation by ethanol.
    Eur J Pharmacol, 593(1): 36-43. [Abstract] [Full-text]
51. "Life events as predictors of mania and depression in bipolar I disorder": Correction to Johnson et al. (2008).
    J Abnorm Psychol, 117(3): 698. [Abstract] [Full-text]
52. Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder.
    J Neural Transm, 115(9): 1339-45. [Abstract] [Full-text]
53. The renin-angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis.
    Epilepsia, 49(8): 1348-57. [Abstract] [Full-text]
54. Hypericum and nurses: a comprehensive literature review on the efficacy of St. John's Wort in the treatment of depression.
    J Holist Nurs, 26(3): 200-7; discussion 208-11. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.